Therapeutic Asset Ratings
141 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Midodrine
Stroke Disorder
Singapore General Hospital
N/A
D
(28)
Nivolumab
Stroke
Karolinska Institutet
N/A
D
(28)
Noradrenaline
Stroke Disorder
Zhejiang Cancer Hospital
N/A
D
(28)
NORMAL HUMAN SERUM ALBUMIN
Stroke Disorder
Rigshospitalet, Denmark
N/A
D
(28)
OTENABANT
Stroke
I.R.C.C.S. Fondazione Santa Lucia
N/A
D
(28)
Pembrolizumab
Stroke
Karolinska Institutet
N/A
D
(28)
Quinine
Stroke
Peking Union Medical College Hospital
D
(28)
Salvianolic Acid
Stroke Disorder
Second Affiliated Hospital, School of Medicine, Zhejiang University
N/A
D
(28)
SARPOGRELATE
Stroke Disorder
Ewha Womans University Seoul Hospital
N/A
D
(28)
Sodium Chloride
Stroke Disorder
Peking Union Medical College Hospital
N/A
D
(28)
SUFENTANIL CITRATE
Stroke
University Hospital Heidelberg
N/A
D
(28)
TACROLIMUS
Stroke
First Affiliated Hospital of Chongqing Medical University
N/A
D
(28)
Tilmanocept
Stroke Disorder
Massachusetts General Hospital
D
(28)
Ulinastatin
Stroke Disorder
Beijing Tiantan Hospital
N/A
D
(28)
Xinglouchengqi Decoction
Stroke Disorder
Peking University Third Hospital
D
(28)
Zoledronate
Stroke Disorder
University of Ioannina
N/A
D
(28)
Showing 126 to 141 of 141 assets
Previous
Page 6 of 6
Next